Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pharmasset
Pharmasset
Biotech Busts And Breakthroughs For September 2011
Forbes
Tue, 10/4/11 - 12:32 pm
Pacific Biosciences
Lexicon Pharmaceuticals
China Pharmaceutical
Momenta
SYNERGY
Caliper Life Sciences
Optimer
MannKind
Pharmasset
Hi-Tech Pharmacal
The Next Big Thing in Biotech: Hep C Drugs (video)
The Street
Sun, 10/2/11 - 12:31 pm
hepatitis C
Vertex
Pharmasset
Idenix
Inhibitex
This Week in Biotech
Motley Fool
Sat, 10/1/11 - 01:51 pm
Pharmasset
GSK
Human Genome Sciences
Vertex Pharmaceuticals
Optimer Pharmaceuticals
Cubist Pharmaceuticals
Array Biopharma
AstraZeneca
Pharmasset Shares Surge on New Hep C Data
TheStreet.com
Fri, 09/30/11 - 12:02 pm
Pharmasset
hepatitis C
PSI-7977
[video] The Next Big Thing In Biotech: Hep C Drugs
TheStreet.com
Fri, 09/30/11 - 11:07 am
hepatitis C
Inhibitex
Vertex
Indenix
Pharmasset
10 Hep C Stocks on Wall Street's Watch List
TheStreet.com
Thu, 09/15/11 - 11:58 am
hepatitis C
Vertex
Merck
Anadyx
Pharmasset
Gilead
Bristol-Myers Squibb
JNJ
Medivir
Achillion
Inhibitex
Indenix
Four Biotech Picks to Fight Hepatitis C
Barron's
Wed, 09/14/11 - 11:07 am
hepatitis C
Achillion
Pharmasset
Inhibitex
Medivir
Vertex
JNJ
Pharmasset climbs after study result released
Yahoo/AP
Tue, 09/6/11 - 12:44 pm
hepatitis C
Pharmasset
PSI-7977
Biotech Busts And Breakthroughs For August
Forbes
Thu, 09/1/11 - 11:34 am
Mako Surgical
Luminex
Regeneron
Pharmasset
ViroPharma
Dendreon
Pacific Biosciences
ZOLL Medical
Savient
Human Genome Sciences
1-Star Stocks Poised to Plunge: Pharmasset?
Motley Fool
Mon, 08/29/11 - 10:59 am
Pharmasset
Buying Into a Hot Hepatitis C Drug Market
Minyanville
Thu, 08/25/11 - 03:44 pm
hepatitis C
Pharmasset
Vertex
Merck
Achillion
Indenix
Inhibitex
INX-189
Incivek
Victrelis
Analyst touts Pharmasset shares
Yahoo/AP
Sat, 08/13/11 - 02:46 pm
Pharmasset
analysis
PSI-7977
hepatitis C
Pharmasset research costs climb in 3Q loss
Yahoo/AP
Mon, 07/25/11 - 07:38 pm
Pharmasset
earnings
These 2 Biotechs Are Dangerous Investments
Motley Fool
Sat, 07/23/11 - 03:16 pm
Pharmasset
Ariad Pharmaceuticals
More Hot Biotech Trades for Second Half 2011
TheStreet.com
Tue, 07/12/11 - 10:27 am
Targacept
Aveo Pharmaceutical
Threshold Pharmaceuticals
Raptor Pharmaceuticals
Vertex Pharmaceuticals
Soligenix
Spectrum Pharmaceuticals
NuPathe
Pharmasset
Incyte
Adventrx
Celsion
Alimera
GTx
Ariad Pharmaceuticals
J&J's Been Busy
Motley Fool
Thu, 07/7/11 - 07:39 pm
JNJ
HIV
Gilead Sciences
Pharmasset
hepatitis C
Pharmasset shares climb after company expands study of hepatitis C drug candidate PSI-7977
Yahoo/AP
Wed, 06/8/11 - 09:36 am
Pharmasset
hepatitis C
PSI-7977
Pharmasset rises as analyst says hepatitis C drug could be approved in 2014, raises target
Yahoo/AP
Fri, 06/3/11 - 10:40 am
Pharmasset
hepatitis C
11 Potential Biotech Buy Out Targets
Seeking Alpha
Wed, 05/18/11 - 11:50 am
M&A
Alexion
Celgene
Biogen Idec
Celldex
Geron
Illumina
Micromet
Mylan
Vical
Oncothyreon
Pharmasset
Pharmasset 2Q loss widens on costs
Yahoo/AP
Mon, 04/25/11 - 09:16 am
earnings
Pharmasset
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »